STRUCTURE-ACTIVITY AND STRUCTURE-AFFINITY RELATIONSHIPS OF 19-NOR-PROGESTERONE DERIVATIVES IN RAT UTERUS

被引：7

作者：

BOTELLA, J ^{[1
]}

DUC, I ^{[1
]}

DELANSORNE, R ^{[1
]}

PARIS, J ^{[1
]}

LAHLOU, B ^{[1
]}

机构：

[1] UNIV NICE,PHYSIOL CELLULAIRE & COMPAREE LAB,F-06034 NICE,FRANCE

来源：

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 1990年 / 13卷 / 11期

关键词：

RECEPTORS; UTERUS; RAT; PROGESTIN; NOMEGESTROL ACETATE;

D O I：

10.1007/BF03349652

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

19-nor-progesterone (19NP) is a potent progestagen which possesses a high affinity for the progesterone receptor (PgR). In contrast, 17-alpha-hydroxylated-progesterone (17OHP) shows no hormonal activity and does not compete with progesterone (P) for the PgR. The aim of the present work was to analyse in parallel the structure-affinity and the structure-activity relationships for new molecules obtained by modifications of 19NP and 17OHP. The attachment of a 17-alpha-hydroxyl group on 19NP led to a dramatic decrease in both affinity and activity for the end-product, 17-alpha-hydroxylated-19-nor-progesterone (17OH-19NP). The further addition of a methyl group combined with the formation of a double-bound at C6 on 17OH-19NP results in nomegestrol (NOM), the relative affinity of which remained low. Negligible activity was also associated with this affinity in comparison to the parent 19NP. Strikingly, the protection of the free 17-alpha-hydroxyl group of NOM by an acetate led to a potent progestin with high affinity for PgR. It is concluded that the sum of the modifications brought into the 17OHP-19NP molecule reestablishes both affinity and activity of the original 19NP molecule. The same conclusion holds if P is considered as the parent compound, as already stated in the literature.

引用

页码：905 / 910

页数：6

共 22 条

[1]

Duax W.L., Griffin J.F., Weeks C.M., Wawrzak Z., The mechanism of action of steroid antagonists: insights from crystallographic studies, J. Steroid Biochem., 31, (1978)

[2]

Duax W.L., Griffin J.F., Rohrer D.C., Weeks C.M., A-Ring conformation and receptor protein binding, J. Steroid Biochem., 9, (1978)

[3]

Delettre J., Mornon J.P., Ojasoo T., Raynaud J.P., An approach to the mapping of the steroid hormone receptor, Perspectives in steroid receptor research, (1980)

[4]

Paris J., Thevenot R., Bonnet P., Granero M., The pharmacological profile of TX066 (17α-acetoxy-6-methyl-19-nor-4,6-pregna-diene-3,20-dione), a new oral progestative, Arzneim. -Forsch. Drug Res., 33, (1983)

[5]

Bazin B., Thevenot R., Bursaux C., Paris J., Effect of nomegestrol acetate, a new 19-nor-progesterone derivative on pituitary-ovarian function in woman, Br. J. Obstet. Gynecol., 94, (1987)

[6]

Botella J., Duc I., Paris J., Delansorne R., Lahlou B., Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19 nor progesterone derivative, J. Pharmacol. Exp. Ther., 248, (1989)

[7]

Muldoon T.G., Regulation of steroid hormone receptor activity, Endocr. Rev., 1, (1980)

[8]

Kassis J.A., Gorski J., On the mechanism of estrogen receptor replenishment: recycling, resynthesis and/or processing, Mol. Cell. Biochem., 52, (1983)

[9]

Thevenot R., Nomegestrol acetate, Drugs of the Future, 9, (1984)

[10]

Rossini G.P., Molybdate inhibits glucocorticoid receptor complex binding to RNA, Mol. Cell. Biochem., 49, (1987)

← 1 2 3 →